Point-of-care Testing
[2023-09-25 11:33:10]
Real time inspection (POCT) can be defined as a laboratory test performed near a patient care site. The POCT corresponds to the user department that needs a quick outcome of the patient sample or is sent to a dedicated remote laboratory (Willmott and Arrowsmith, 2010). Junker et al. (2010), POCT can conduct a series of tests including blood glucose measurement, blood gas and electrolyte, urea, creatinine, troponin, bilirubin and coagulation test.
Point-of-care testing is important to quickly detect samples on the patient's site for improved diagnosis, monitoring and management of the disease. At the time of the care test, the disease is diagnosed early and healthcare professionals not only allow for rapid medical judgment but also improve the patient's health by initiating treatment early. Recent nursing exams have seen significant progress. Among these are the development of biosensors, analytical formats, microfluidics, lab-on-a-chip technology, bioanalysis platforms, complementary technologies. Today, the point-of-care test system provides an extensive test menu that wirelessly transmits test results to a patient's medical record for doctor's consultation.
A medical point test (POCT), also called a bedside test, is a medical diagnostic test that enables a patient to perform a diagnosis on site, ambulance, clinic, hospital, or home. The results of the point-of-care test are timely and accurate, enabling rapid patient treatment. By solving the problem of health difference in real time, medical examination may have a wide influence on medical system. Success from repairing drugs, potential transitions to remedial, prognostic and prophylactic drugs may depend on enhancing diagnostic equipment for portable monitoring and point of care testing
Point-of-care testing devices provide advantageous, quick and reliable test results and have the advantage of testing near the patient. Medical test markets are expected to grow significantly in the near future due to increased incidence of chronic and infectious diseases, increased familial health care preferences, increased elderly and advances in technology related to smartphone based applications I will.
Worldwide, the ability to rapidly diagnose drug - resistant tuberculosis is very limited. Several new TB tests such as Genexpert test and TrueNat test are available. However, in areas where the burden of tuberculosis is the biggest, there is little point-of-care examination yet. In order to overcome the problem of drug-resistant tuberculosis, it is necessary to develop an actual point-of-care drug susceptibility test and implement it at an affordable cost.